Doctor profile · Federal record
Dr. ELANGOVAN BALAKRISHNAN, MD
Hematology & Oncology Physician (CMS: HEMATOLOGY/ONCOLOGY) · COLUMBIA, MO
- NPI 1407843022
- Accepts Medicare
- MIPS 89.6 / 100 · 2023
- 25 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
1705 E BROADWAY, SUITE 100
COLUMBIA, MO 652015852
(573) 874-7800
fax (573) 443-3627 - Additional location
-
603 W Pierce St
Kirksville, MO 635011448
(660) 785-1050
fax (660) 785-1055 - Mailing address
-
1705 E BROADWAY STE 100
COLUMBIA, MO 652017167
Credentials & registration
- NPI registered
- September 2005 — 21 yrs on file
- Profile last updated
- January 30, 2025
- Year of graduation
- 2001 — 25 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Missouri #2004024397
- Medicaid
- MO #209024306
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1407843022. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
296,262
Distinct HCPCS
10
Medicare allowed
$3,975,683
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 60,900 | 74 | $3 | |
J0641 |
Injection, levoleucovorin, not otherwise specified, 0.5 mg | 30,800 | 18 | $1 | |
J9271 |
Injection, pembrolizumab, 1 mg | 28,200 | 49 | $54 | |
J1439 |
Injection, ferric carboxymaltose, 1 mg | 22,500 | 27 | $1 | |
J9299 |
Injection, nivolumab, 1 mg | 19,300 | 15 | $30 | |
Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 18,901 | 171 | $0 | |
J9025 |
Injection, azacitidine, 1 mg | 18,700 | 16 | $0 | |
J0185 |
Injection, aprepitant, 1 mg | 14,170 | 56 | $2 | |
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 13,770 | 24 | $1 | |
J9267 |
Injection, paclitaxel, 1 mg | 13,575 | 34 | $0 |
In context: peer comparison
Among 9 peers in this city , average services per provider: 3,643. This provider delivers 81× the peer median.Open Payments
Industry payments received
All-time total
$1,043
Transactions
41
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 6 | $148.05 | |
| Daiichi Sankyo Inc. | 4 | $97.58 | |
| EMD Serono, Inc. | 4 | $86.40 | |
| Novartis Pharmaceuticals Corporation | 3 | $69.65 | |
| Celgene Corporation | 4 | $68.89 | |
| PFIZER INC. | 3 | $63.97 | |
| AstraZeneca Pharmaceuticals LP | 2 | $47.75 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $43.48 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40.06 | |
| Eisai Inc. | 2 | $38.96 | |
| GlaxoSmithKline, LLC. | 2 | $36.38 | |
| Merck Sharp & Dohme LLC | 2 | $31.30 | |
| GENZYME CORPORATION | 2 | $29.73 | |
| Genentech USA, Inc. | 2 | $29.61 | |
| Janssen Biotech, Inc. | 1 | $24.86 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,403
Patients
435
Total drug cost
$62,990
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 202 | 55 | $8,121 |
| Prochlorperazine Maleate | Generic | 160 | 78 | $2,311 |
| Letrozole | Generic | 114 | 20 | $2,361 |
| Potassium Chloride | Generic | 110 | 37 | $2,677 |
| Omeprazole | Generic | 101 | 20 | $1,504 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 97 | 35 | $3,398 |
| Levothyroxine Sodium | Generic | 97 | 23 | $1,172 |
| Prednisone | Generic | 89 | 30 | $728 |
| Gabapentin | Generic | 79 | 17 | $1,781 |
| Hydroxyurea | Generic | 79 | 12 | $1,556 |